Graham BS - Search Results

1

Attenuated Human Parainfluenza Virus Type 1 Expressing the Respiratory Syncytial Virus (RSV) Fusion (F) Glycoprotein from an Added Gene: Effects of Prefusion Stabilization and Packaging of RSV F.

Liu X, Liang B, Ngwuta J, Liu X, Surman S, Lingemann M, Kwong PD, Graham BS, Collins PL, Munir S. Liu X, et al. Among authors: graham bs. J Virol. 2017 Oct 27;91(22):e01101-17. doi: 10.1128/JVI.01101-17. Print 2017 Nov 15. J Virol. 2017. PMID: 28835504 Free PMC article.

2

Construction and characterization of recombinant vaccinia viruses co-expressing a respiratory syncytial virus protein and a cytokine.

Johnson TR, Fischer JE, Graham BS. Johnson TR, et al. Among authors: graham bs. J Gen Virol. 2001 Sep;82(Pt 9):2107-2116. doi: 10.1099/0022-1317-82-9-2107. J Gen Virol. 2001. PMID: 11514719

3

NK T cells contribute to expansion of CD8(+) T cells and amplification of antiviral immune responses to respiratory syncytial virus.

Johnson TR, Hong S, Van Kaer L, Koezuka Y, Graham BS. Johnson TR, et al. Among authors: graham bs. J Virol. 2002 May;76(9):4294-303. doi: 10.1128/jvi.76.9.4294-4303.2002. J Virol. 2002. PMID: 11932395 Free PMC article.

4

Respiratory syncytial virus immunobiology and pathogenesis.

Graham BS, Rutigliano JA, Johnson TR. Graham BS, et al. Virology. 2002 May 25;297(1):1-7. doi: 10.1006/viro.2002.1431. Virology. 2002. PMID: 12083830 Free article. Review. No abstract available.

5

Role of plasma membrane lipid microdomains in respiratory syncytial virus filament formation.

McCurdy LH, Graham BS. McCurdy LH, et al. Among authors: graham bs. J Virol. 2003 Feb;77(3):1747-56. doi: 10.1128/jvi.77.3.1747-1756.2003. J Virol. 2003. PMID: 12525608 Free PMC article.

6

IL-13 is sufficient for respiratory syncytial virus G glycoprotein-induced eosinophilia after respiratory syncytial virus challenge.

Johnson TR, Parker RA, Johnson JE, Graham BS. Johnson TR, et al. Among authors: graham bs. J Immunol. 2003 Feb 15;170(4):2037-45. doi: 10.4049/jimmunol.170.4.2037. J Immunol. 2003. PMID: 12574374

7

Contribution of respiratory syncytial virus G antigenicity to vaccine-enhanced illness and the implications for severe disease during primary respiratory syncytial virus infection.

Johnson TR, Graham BS. Johnson TR, et al. Among authors: graham bs. Pediatr Infect Dis J. 2004 Jan;23(1 Suppl):S46-57. doi: 10.1097/01.inf.0000108192.94692.d2. Pediatr Infect Dis J. 2004. PMID: 14730270 Review.

8

Treatment with anti-LFA-1 delays the CD8+ cytotoxic-T-lymphocyte response and viral clearance in mice with primary respiratory syncytial virus infection.

Rutigliano JA, Johnson TR, Hollinger TN, Fischer JE, Aung S, Graham BS. Rutigliano JA, et al. Among authors: graham bs. J Virol. 2004 Mar;78(6):3014-23. doi: 10.1128/jvi.78.6.3014-3023.2004. J Virol. 2004. PMID: 14990720 Free PMC article.

9

RhoA-derived peptide dimers share mechanistic properties with other polyanionic inhibitors of respiratory syncytial virus (RSV), including disruption of viral attachment and dependence on RSV G.

Budge PJ, Li Y, Beeler JA, Graham BS. Budge PJ, et al. Among authors: graham bs. J Virol. 2004 May;78(10):5015-22. doi: 10.1128/jvi.78.10.5015-5022.2004. J Virol. 2004. PMID: 15113882 Free PMC article.

10

Respiratory syncytial virus (RSV) G glycoprotein is not necessary for vaccine-enhanced disease induced by immunization with formalin-inactivated RSV.

Johnson TR, Teng MN, Collins PL, Graham BS. Johnson TR, et al. Among authors: graham bs. J Virol. 2004 Jun;78(11):6024-32. doi: 10.1128/JVI.78.11.6024-6032.2004. J Virol. 2004. PMID: 15141000 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

587 results

Search Page

Filters